dpp-4 inhibitor and glp-1 receptor agonist combination inhibitors GLP-1RAs: cardiovascular safety and benefits Insight into Structure Activity Relationship
Description
J Biol Res (Thessalon)
GLP-1 (glucagon-like peptide-1) receptor agonists form a class of medications that clinicians originally developed to help manage type 2 diabetes
Using these findings, they estimated a 5-year number needed to harm, between 1349 and 1562 (Table 2)
Do GLP-1 Patches Actually Work
The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases
None of these look anything like a large GLP-1 analog peptide under the antibody-based assays used in standard testing
